Director, Analytical and Bioanalytical Operations
Bristol Myers Squibb Company
Princeton, New Jersey
Dr. Yan Zhang is currently a Director in Bioanalytical Sciences of Bristol-Myers Squibb, leading a team of scientists on developing ligand-binding assays and LC-MS based bioanalytical assays for the assessment of PK, immunogenicity, and biomarkers in support of BMS discovery biologics and clinical biomarker programs. She joined BMS in 2006 and has taken increased responsibilities in Bioanalytical Sciences and Clinical Biomarker Development. Prior to BMS, Yan worked for GlaxoSmithKline where she managed and implemented clinical biomarker and assay technology development projects. Her previous work experience includes supporting the bioprocess development of DNA-based therapeutics in Bioprocessing Technology Centre in Singapore, and managing and monitoring clinical studies in GlaxoWellcome China in Hong Kong. She earned her Ph.D. degree in Cellular and Molecular Biology at the New York University and had her postdoctoral training at Howard Hughes Institute in University of Pennsylvania.